Anthony Ignagni
President & CEO
Anthony Ignagni')>
Anthony R. Ignagni is the President & CEO of Synapse Biomedical, as well as a co-founder. He brings to the company over 30 years of experience in the development and commercialization of neurostimulation medical devices. He received his Bachelors and Masters degrees in Biomedical Engineering from Case
Western Reserve University and managed software development at the Cleveland FES Center for eleven years. As a founding member of NeuroControl Corp. and VP of New Product Development & Operations, he has brought neurostim devices to market in the US and Europe.
Western Reserve University and managed software development at the Cleveland FES Center for eleven years. As a founding member of NeuroControl Corp. and VP of New Product Development & Operations, he has brought neurostim devices to market in the US and Europe.
Oberlin, United States
Healthcare
About
Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in Spinal Cord Injuries, and in respiratory short-term intensive care settings.
This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in Spinal Cord Injuries, and in respiratory short-term intensive care settings.
Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link